Lykele van der Broek is the new Head of the Animal Health Division and member of Bayer HealthCare Executive Commitee
Monday - October 2, 2006 - Leverkusen – Effective October 1st, 2006, Lykele van der Broek has been appointed as Head of Animal Health Division and member of the Bayer HealthCare (BHC) Executive Committee. He succeeds Peter Nicklin, who left Bayer HealthCare to persue other job opportunities effective on the same date.
Lykele van der Broek is Dutch and is graduated from the Agricultural University in Wageningen (Netherlands) with a Master of Science specializing in Phytopathology and Business Adminstration.
Van der Broek started his career at the Plant Protection Service of Netherlands. From 1984 to 1991, he acted as Deputy Director and Director of the Netherlands Inspection Service for Arboriculture (NAKB). He then held different positions in BioScience companies. On joining Nunza (now Nunhems), a vegetable seed group, in 1999 he was responsible for Asia Pacific and strategy. In 2001 he became CEO and continued this position after Bayer’s the acquisition of Aventis CropScience in 2002. In 2003 he was appointed Head of BioScience, a business group within Bayer CropScience, before changing into the position as Head of Regional Coordination Europe at Bayer AG.
Lykele van der Broek is married with three children.
Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the health care and medical products industry based in Leverkusen/Germany. In 2005, the Bayer HealthCare subgroup generated sales amounting to some 9.4 billion Euro. Bayer HealthCare employed 33.800 people worldwide in 2005.
The company combines the global activities of the divisions Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. Since January 1, 2006 the new Pharmaceutical Division consists of the former Biological Products and Pharmaceutical Division and now comprises three business units: Hematology/Cardiology, Oncology and Primary Care.
Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide. The products enhance well-being and quality of life by diagnosing, preventing and treating diseases.
We are only one click away – our press service online: www.viva.vita.bayerhealthcare.com
This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including our Form 20-F).The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
- Contact Information
- Dr. Hermann-Josef Baaken
- BayHealthNews Health Press Service
- Bayer HealthCare AG
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.